---
title: "GLP-1 Receptor Agonist"
description: "GLP-1 receptor agonists (GLP-1 RAs) are a drug class including semaglutide and liraglutide for diabetes and obesity in India."
canonical: "https://www.kesho.health/glossary/glp-1-receptor-agonist"
markdown_url: "https://www.kesho.health/md/glossary/glp-1-receptor-agonist"
language: "en-IN"
---

# GLP-1 Receptor Agonist

**Canonical HTML:** https://www.kesho.health/glossary/glp-1-receptor-agonist  
**Markdown:** https://www.kesho.health/md/glossary/glp-1-receptor-agonist

## Definition

A GLP-1 receptor agonist is a medication that activates GLP-1 receptors to improve blood sugar control and reduce appetite.

## Extended

This drug class—not a single brand—includes semaglutide, liraglutide, dulaglutide, and dual-acting tirzepatide (GIP/GLP-1). Indian patients require CDSCO-approved products and valid prescriptions. In India, these concepts appear in RSSDI and ICMR guidance for type 2 diabetes and obesity care—always confirm details with your prescribing physician.

## Learn more

[Full guide](https://www.kesho.health/blog/glp-1-explained-india) · [MD](https://www.kesho.health/md/blog/glp-1-explained-india)

## Related terms

- [glp-1](https://www.kesho.health/glossary/glp-1)
- [semaglutide](https://www.kesho.health/glossary/semaglutide)
- [tirzepatide](https://www.kesho.health/glossary/tirzepatide)
- [incretin](https://www.kesho.health/glossary/incretin)